Decoy Therapeutics Inc. (DCOY)
NASDAQ: DCOY · Real-Time Price · USD
3.200
-0.080 (-2.44%)
At close: Aug 21, 2026, 4:00 PM EDT
3.260
+0.060 (1.87%)
After-hours: Aug 21, 2026, 7:48 PM EDT
Decoy Therapeutics Revenue
Decoy Therapeutics had revenue of $227.63K in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to $227.63K.
Revenue (ttm)
$227.63K
Revenue Growth
n/a
P/S Ratio
9.21
Revenue / Employee
$20,694
Employees
11
Market Cap
2.10M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 1.84M | -3.39M | -64.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
DCOY News
- 11 days ago - Decoy Therapeutics Quarterly report: Q2 2026 - Filings
- 19 days ago - Decoy Therapeutics Proxy statement: Proxy filing - Filings
- 19 days ago - Decoy Therapeutics Proxy statement: Proxy filing - Filings
- 20 days ago - Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMP³ACT™ Platform - PRNewsWire
- 27 days ago - Decoy Therapeutics’ D-MAV platform shows inhibition of Ebola Zaire virus - TheFly
- 27 days ago - Decoy Therapeutics Announces Breakthrough In Vitro Activity Against Ebola Zaire, Expanding D-MAV™ Platform into High Consequence Global Health Threats - PRNewsWire
- 4 weeks ago - Decoy Therapeutics Proxy statement: Proxy filing - Filings
- 5 weeks ago - Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors - PRNewsWire